These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

446 related items for PubMed ID: 10583575

  • 1. Expression of MUC1 and MUC2 mucin gene products in Barrett's metaplasia, dysplasia and adenocarcinoma: an immunopathological study with clinical correlation.
    Chinyama CN, Marshall RE, Owen WJ, Mason RC, Kothari D, Wilkinson ML, Sanderson JD.
    Histopathology; 1999 Dec; 35(6):517-24. PubMed ID: 10583575
    [Abstract] [Full Text] [Related]

  • 2. Mucin core polypeptide expression in the progression of neoplasia in Barrett's esophagus.
    Glickman JN, Blount PL, Sanchez CA, Cowan DS, Wongsurawat VJ, Reid BJ, Odze RD.
    Hum Pathol; 2006 Oct; 37(10):1304-15. PubMed ID: 16949933
    [Abstract] [Full Text] [Related]

  • 3. Mucin expression profile in Barrett's, dysplasia, adenocarcinoma sequence in the esophagus.
    Burjonrappa SC, Reddimasu S, Nawaz Z, Gao X, Sharma P, Loggie B.
    Indian J Cancer; 2007 Oct; 44(1):1-5. PubMed ID: 17401217
    [Abstract] [Full Text] [Related]

  • 4. Immunoreactivity of cytokeratins (CK7, CK20) and mucin peptide core antigens (MUC1, MUC2, MUC5AC) in adenocarcinomas, normal and metaplastic tissues of the distal oesophagus, oesophago-gastric junction and proximal stomach.
    Flucke U, Steinborn E, Dries V, Mönig SP, Schneider PM, Thiele J, Hölscher AH, Dienes HP, Baldus SE.
    Histopathology; 2003 Aug; 43(2):127-34. PubMed ID: 12877727
    [Abstract] [Full Text] [Related]

  • 5. Mucin gene expression in Barrett's oesophagus: an in situ hybridisation and immunohistochemical study.
    Arul GS, Moorghen M, Myerscough N, Alderson DA, Spicer RD, Corfield AP.
    Gut; 2000 Dec; 47(6):753-61. PubMed ID: 11076872
    [Abstract] [Full Text] [Related]

  • 6. Mucin gene expression and cell differentiation in human normal, premalignant and malignant esophagus.
    Guillem P, Billeret V, Buisine MP, Flejou JF, Lecomte-Houcke M, Degand P, Aubert JP, Triboulet JP, Porchet N.
    Int J Cancer; 2000 Dec 15; 88(6):856-61. PubMed ID: 11093805
    [Abstract] [Full Text] [Related]

  • 7. Expression of sulfated carbohydrate chain and core peptides of mucin detected by monoclonal antibodies in Barrett's esophagus and esophageal adenocarcinoma.
    Endo T, Tamaki K, Arimura Y, Itoh F, Hinoda Y, Hareyama M, Irimura T, Fujita M, Imai K.
    J Gastroenterol; 1998 Dec 15; 33(6):811-5. PubMed ID: 9853552
    [Abstract] [Full Text] [Related]

  • 8. Expression profile and cellular localizations of mucin proteins, CK7, and cytoplasmic p27 in Barrett's esophagus and esophageal adenocarcinoma.
    Ozcan HEA, Anuk T, Ozden O.
    Adv Med Sci; 2018 Sep 15; 63(2):296-300. PubMed ID: 29803118
    [Abstract] [Full Text] [Related]

  • 9. Mucin expression and proliferating cell index of esophageal Barrett's adenocarcinoma.
    Yamamoto S, Kijima H, Hara T, Chino O, Shimada H, Tanaka M, Inokuchi S, Makuuchi H.
    Int J Mol Med; 2005 Sep 15; 16(3):375-80. PubMed ID: 16077942
    [Abstract] [Full Text] [Related]

  • 10. Gastric-type mucin and TFF-peptide expression in Barrett's oesophagus is disturbed during increased expression of MUC2.
    Van De Bovenkamp JH, Korteland-Van Male AM, Warson C, Büller HA, Einerhand AW, Ectors NL, Dekker J.
    Histopathology; 2003 Jun 15; 42(6):555-65. PubMed ID: 12786891
    [Abstract] [Full Text] [Related]

  • 11. Phenotypic differences between esophageal and gastric intestinal metaplasia.
    Piazuelo MB, Haque S, Delgado A, Du JX, Rodriguez F, Correa P.
    Mod Pathol; 2004 Jan 15; 17(1):62-74. PubMed ID: 14631367
    [Abstract] [Full Text] [Related]

  • 12. Differential expression of mucins and trefoil peptides in native epithelium, Barrett's metaplasia and squamous cell carcinoma of the oesophagus.
    Labouvie C, Machado JC, Carneiro F, Sarbia M, Vieth M, Porschen R, Seitz G, Blin N.
    J Cancer Res Clin Oncol; 1999 Jan 15; 125(2):71-6. PubMed ID: 10190312
    [Abstract] [Full Text] [Related]

  • 13. Cdx2 expression and its promoter methylation during metaplasia-dysplasia-carcinoma sequence in Barrett's esophagus.
    Makita K, Kitazawa R, Semba S, Fujiishi K, Nakagawa M, Haraguchi R, Kitazawa S.
    World J Gastroenterol; 2013 Jan 28; 19(4):536-41. PubMed ID: 23382633
    [Abstract] [Full Text] [Related]

  • 14. Cdx2 as a marker of epithelial intestinal differentiation in the esophagus.
    Phillips RW, Frierson HF, Moskaluk CA.
    Am J Surg Pathol; 2003 Nov 28; 27(11):1442-7. PubMed ID: 14576477
    [Abstract] [Full Text] [Related]

  • 15. Proinflammatory cytokine and nuclear factor kappa-B expression along the inflammation-metaplasia-dysplasia-adenocarcinoma sequence in the esophagus.
    O'Riordan JM, Abdel-latif MM, Ravi N, McNamara D, Byrne PJ, McDonald GS, Keeling PW, Kelleher D, Reynolds JV.
    Am J Gastroenterol; 2005 Jun 28; 100(6):1257-64. PubMed ID: 15929754
    [Abstract] [Full Text] [Related]

  • 16. MUC4 is increased in high grade intraepithelial neoplasia in Barrett's oesophagus and is associated with a proapoptotic Bax to Bcl-2 ratio.
    Bax DA, Haringsma J, Einerhand AW, van Dekken H, Blok P, Siersema PD, Kuipers EJ, Kusters JG.
    J Clin Pathol; 2004 Dec 28; 57(12):1267-72. PubMed ID: 15563666
    [Abstract] [Full Text] [Related]

  • 17. Time gated fluorescence spectroscopy in Barrett's oesophagus.
    Ortner MA, Ebert B, Hein E, Zumbusch K, Nolte D, Sukowski U, Weber-Eibel J, Fleige B, Dietel M, Stolte M, Oberhuber G, Porschen R, Klump B, Hörtnagl H, Lochs H, Rinneberg H.
    Gut; 2003 Jan 28; 52(1):28-33. PubMed ID: 12477755
    [Abstract] [Full Text] [Related]

  • 18. Cytokeratin 7/20 and MUC1, 2, 5AC, and 6 expression patterns in Barrett's esophagus and intestinal metaplasia of the stomach: intestinal metaplasia of the cardia is related to Barrett's esophagus.
    Gulmann C, Shaqaqi OA, Grace A, Leader M, Patchett S, Butler D, Kay E.
    Appl Immunohistochem Mol Morphol; 2004 Jun 28; 12(2):142-7. PubMed ID: 15354740
    [Abstract] [Full Text] [Related]

  • 19. CDX2, COX2 and MUC2 expressions in Barrett's esophagus: can they be useful in determination of the dysplasia?
    Türkmen IÇ, Başsüllü N, Uraz S, Yerdel MA, Memışoğlu R, Bülbül Doğusoy G.
    Turk Patoloji Derg; 2012 Jun 28; 28(3):251-8. PubMed ID: 23011828
    [Abstract] [Full Text] [Related]

  • 20. Clinical impact of MUC1 and MUC4 expression in Barrett-associated oesophageal adenocarcinoma.
    Piessen G, Wacrenier A, Briez N, Triboulet JP, Van Seuningen I, Mariette C.
    J Clin Pathol; 2009 Dec 28; 62(12):1144-6. PubMed ID: 19946103
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.